✓ Independent editorial reviews of U.S. telehealth programs · Prices and dates shown on each page · Educational only — not medical advice
Recovery · Provider Directory

Recovery & Healing Peptides

Released: Last reviewed:

Recovery peptides target soft-tissue healing, gut barrier repair, and inflammation modulation. The most-prescribed compounds via U.S. telehealth in 2026 are BPC-157, TB-500, KPV, and the dual stack BPC-157/TB-500. None of these is FDA-approved, and as of October 15, 2026 BPC-157, TB-500, KPV and LL-37 have no recognized federal pathway for 503A compounding from bulk; only non-injectable GHK-Cu is in FDA’s Category 1.

7 peptides covered v4.1 methodology All 50 states + DC
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.

Peptides in this category

Recovery
BPC-157
Body Protection Compound-157
 Recovery
TB-500
Thymosin Beta-4 fragment
 Recovery
GHK-Cu
Copper peptide, skin & connective tissue
 Recovery
Pentadeca Arginate
PDA, novel synthetic
 Recovery
LL-37
Antimicrobial cathelicidin
 Recovery
KPV
Anti-inflammatory tripeptide
 Recovery
DSIP
Delta Sleep-Inducing Peptide

Top telehealth providers for recovery

See the full provider directory for profiles, dated prices and scores.

Editorial team

Researched by Dr. Parmis (Medical Researcher, Western University of Health Sciences); medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC).

Related categories